Clinical Research Directory
Browse clinical research sites, groups, and studies.
Comparison of Esomeprazole Versus Vonoprazan in Gastroesophageal Reflux Disease
Sponsor: Muhammad Aamir Latif
Summary
Local literature is deprived of data comparing the effectiveness of esomeprazole and vonoprazan in patients with gastroesophageal reflux disease (GERD). This study was planned with the objective of comparing the effectiveness of esomeprazole versus vonoprazan in patients diagnosed with GERD.
Official title: Comparison of Effectiveness in Patients of Gastroesophageal Reflux Disease Taking Esomeprazole Versus Vonoprazan.
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
824
Start Date
2025-01-01
Completion Date
2025-09-30
Last Updated
2026-05-04
Healthy Volunteers
No
Conditions
Interventions
Esomeprazole
Patients received a once-daily dose of 20 mg of esomeprazole after the evening meal for 4 weeks.
Vonoprazan
Patients received a once-daily dose of 20 mg of vonoprazan after the evening meal for 4 weeks.
Locations (1)
Allama Iqbal teaching hospital
Dera Ghazi Khan, Punjab Province, Pakistan